POSTER SESSION IV
Tuesday, March 20, 2012   —  1:00 PM - 4:30 PM
CC Exhibit Hall B3 & C


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...




LIVER PATHOLOGY



Poster#Title and AuthorsItinerary
Planner
234 Expression of Calretinin and CK5/6 in Cholangiocarcinoma (1777)
L Zhang, R Frank, EE Furth, AF Ziober, VA LiVolsi, PJ Zhang - University Medical Center at Princeton, Princeton, NJ; University of Pennsylvania Medical Center, Philadelphia, Philadelphia, PA
Add
235 Ki-67 and p53 Expression as an Immunohistochemical Tool in the Differential Diagnosis of Benign and Malignant Biliary Lesions (1738)
G Krings, L Ferrell, R Gill - Univ Calif, San Francisco
Add
236 IgG4 Reaction in Biliary Cancers – Signification and Mechanism (1730)
K Harada, Y Nakanuma - Kanazawa University Graduate School of Medicine, Kanazawa, Ishikawa, Japan
Add
237 The Overexpression of Enhancer of Zeste Homolog 2 (EZH2) May Be Related to Malignant Behaviors in Intraductal Papillary Neoplasm of the Bile Duct (1767)
M Sasaki, T Matsubara, Y Sato, N Yoneda, Y Nakanuma - Kanazawa University Graduate School of Medicine, Kanazawa, Japan
Add
238 Epistein-Barr Virus Associated Primary Intrahepatic Lymphoepithelioma-Like Cholangiocarcinoma (1722)
AWH Chan, JHM Tong, MYM Sung, PBS Lai, K To - The Chinese University of Hong Kong
Add
239 Giant and Small Cavernous Hemangiomas of the Liver: A Clinicopathologic Comparison Including Hemangioma-Like Vessels (1778)
Q Zhao, M Taggart, SC Abraham - MD Anderson Cancer Center, Houston
Add
240 Characterization of Translocations in Mesenchymal Hamartoma of the Liver by Targeted Next Generation Sequencing of Formalin-Fixed Paraffin-Embedded Tissue (1747)
J Mathews, E Duncavage, J Pfeifer - Washington University School of Medicine, St. Louis
Add
241 Small Vessel Hepatic Hemangioma, an Atypical Hemangioma Variant in Adult Liver (1726)
R Gill, V Alves, H Makhlouf, C Sempoux, S Thung, L Ferrell - UCSF, San Francisco; Univ. of Sao Paulo/Medicine, Sao Paulo, Brazil; AFIP, Washington, DC; Universite Catholique de Louvain, Brussels, Belgium; Mt. Sinai Med. Ctr. Sch/Med., New York
Add
242 Evaluation of Prognostic Markers in Metastatic Well- Differentiated Neuroendocrine Tumors to the Liver (1774)
Z Yang, LH Tang, DS Klimstra - Penn State Milton S. Hershey Medical Center, Hershey, PA; Memorial Sloan-Kettering Cancer Center, New York, NY
Add
243 Low Proliferation/Apoptosis Ratio in Early Biopsies Predicts Adverse Outcome in Cardiac Death Donor Liver Allografts (1769)
l Siniavskaia, s Hafezi-Bakhtiari, o Adeyi - University of Toronto & University Health Network, Toronto, ON, Canada
Add
244 Retransplantation for Fibrosing Cholestatic Hepatitis C (FCH): Outcomes in a Series of 9 Cases (1766)
M Salomao, EC Verna, RK Moreira - Columbia University, New York, NY
Add
245 Long-Term Outcome of Patients Transplanted for Primary Biliary Cirrhosis: Follow-Up > 60 Months (1739)
M Krishna, DM Harnois, BG Rosser, RE Nakhleh - Mayo Clinic, Jacksonville, FL
Add